Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$8.48 - $11.13 $16,960 - $22,260
-2,000 Reduced 47.79%
2,185 $288,000
Q2 2022

Jul 22, 2022

BUY
$9.95 - $12.27 $17,521 - $21,607
1,761 Added 72.65%
4,185 $43,000
Q1 2022

May 11, 2022

BUY
$9.81 - $15.4 $23,769 - $37,314
2,423 Added 242300.0%
2,424 $26,000
Q3 2021

Nov 02, 2021

SELL
$13.25 - $15.13 $1,841 - $2,103
-139 Reduced 99.29%
1 $0
Q2 2021

Aug 02, 2021

BUY
$12.97 - $16.15 $1,400 - $1,744
108 Added 337.5%
140 $2,000
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $457 - $599
32 New
32 $1,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hbc Financial Services, Pllc Portfolio

Follow Hbc Financial Services, Pllc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbc Financial Services, Pllc, based on Form 13F filings with the SEC.

News

Stay updated on Hbc Financial Services, Pllc with notifications on news.